Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 24, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Femoroacetabular Impingement
Interventions
DRUG

Fisetin

Oral Fisetin 20 mg/kg taken for 8 days total.

DRUG

Placebo

Fisetin appearance-matched microcrystalline cellulose placebo. 20 mg/kg taken for 8 days total.

Trial Locations (1)

81657

The Steadman Clinic, Vail

All Listed Sponsors
lead

Steadman Philippon Research Institute

OTHER

collaborator

United States Department of Defense

FED